In a webinar series geared towards providers to individuals living with Tourette Syndrome, the TAA has identified relevant topics to support the community’s needs. The series will cover diagnosis, management, treatment as well as discussions of Tourette Syndrome’s co-occurring conditions such as OCD and ADHD. CME credit is available upon completion.
Webinar 1: Cognitive Behavioral Therapy for OCD
Presenter: Dr. Sabine Wilhelm
Description: This webinar was suitable for all providers interested in working with patients suffering from Obsessive Compulsive Disorder (OCD).
It reviewed the assessment of OCD as well as evidence-based interventions such as psychoeducation, cognitive strategies, mindfulness, exposure and response prevention.
The webinar focused on the integration of different treatment strategies for the different types of OCD symptoms. The impact of common comorbidities, strategies to address treatment non-adherence to maintain treatment gains were also discussed.
Dr. Sabine Wilhelm is the Chief of Psychology and the Director of the Obsessive-Compulsive and Related Disorders Program at Massachusetts General Hospital. She is a Professor of Psychology (Psychiatry) at Harvard Medical School.
Dr. Wilhelm is recognized as a leading researcher in obsessive-compulsive and related disorders, and has published 270 articles and reviews on cognitive functioning, prevalence and treatment outcomes of these disorders. She is especially interested in the development and testing of new technologies to treat illness and improve quality of life. She has also given more than 220 lectures on these subjects. Dr. Wilhelm has published seven books on OCD and related disorders.
She has been a mentor to more than 40 junior investigators in the field. Dr. Wilhelm is the Vice Chair of the Scientific Advisory Board of the International OCD Foundation, and she serves on the Scientific Council for the Anxiety and Depression Association of America as well as on the Tourette Syndrome Association Behavioral Science Consortium.
Dr. Wilhelm is past President for the Association for Behavioral and Cognitive Therapies (ABCT). Dr. Wilhelm was an Associate Editor for the journals Depression and Anxiety and Behavior Therapy. She currently serves on eight editorial boards. In 2002, she was awarded the Claflin Distinguished Scholar in Medicine Award. She was named a Beck Institute Scholar in 2003, and was also the Scientific Program Chair of the World Congress of Behavioral and Cognitive Therapies held in Boston in June 2010. Additionally, Dr. Wilhelm is a fellow of the Association for Psychological Science. In 2018 Dr. Wilhelm received the Peter K. Ranney Innovation Award from the World Medical Innovation Forum at Partners HealthCare for her presentation “Bridging the Mental Health Treatment Gap.” In addition, she was awarded the Aaron T. Beck Award presented by the Academy of Cognitive Therapy in 2018.
Dr. Wilhelm has been the principal investigator or site principal investigator of seven NIMH-funded research grants. She is also the principal investigator of several privately-funded clinical research studies investigating medication, cognitive-behavioral therapy, digital services, and other treatments for OCD and related disorders in children and adults.
Webinar 2: Diagnosing Tourette Syndrome and Initial Considerations
Presenter: Dr. John Walkup
Description: This webinar was suitable for all providers who are interested in working with patients dealing with Tourette Syndrome.
Dr. John T. Walkup is Professor of Psychiatry, Northwestern Feinberg School of Medicine and Chair, the Department of Child and Adolescent Psychiatry, Ann and Robert H. Lurie Children’s Hospital of Chicago. He recently moved to Northwestern after being the Division Director of Child and Adolescent Psychiatry at Weill Cornell Medical College in New York City. He is also an Adjunct Professor in the Center for American Indian Health at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine.
Dr. Walkup is one of a very small and elite group of academic child and adolescent psychiatrists in the United States. His work covers three main areas of innovation and investigation. His work with movement disorders, specifically Tourette syndrome, uniquely spans psychiatry, child psychiatry and neurology. His expertise in child and adolescent psychiatry clinical trials focuses on the development and evaluation of psychopharmacological and psychosocial treatments and lastly, he has been involved in developing and evaluating interventions to reduce the large mental health disparities facing Native American youth, specifically drug use and suicide prevention. Over his career, Dr. Walkup has been awarded over $20 million in grants and contracts to support his research.
His capacity to apply research methodologies across numerous neuropsychiatric disorders and his extension of that skill to address mental health disparities in Native American youth make him a singularly unique contributor to psychiatry, neurology and public health.
For his work, he has been awarded three United States achievement awards for child and adolescent psychiatry, the Norbert and Charlotte Rieger Award for Academic Achievement in 2009 from the American Academy of Child and Adolescent Psychiatry, the Blanche F. Ittleson Award for Research in Child Psychiatry in 2011 from the American Psychiatric Association and the Schonfeld Award from the American Society of Adolescent Psychiatry in 2016.
A recent paper of his (Walkup JT. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies. Am J Psychiatry. 2017 May 1;174(5):430-437 was considered by the editor of the American Journal of Psychiatry, Robert Freedman, MD, his choice for ‘Paper of the Year’. He has also served as a member of two National Academy (IOM) Committees on Developing Evidence-Based Standards for Psychosocial Interventions for Mental Disorders and Improving Health Outcomes for Children with Disabilities. He currently serves as a Counselor-at-Large for the American Academy of Child and Adolescent Psychiatry. He is also a Member of the Board of Director of the Tourette Association of America.
Evidence-Based Treatment and Management of Tourette Syndrome
Presenter: Dr. Tamara Pringsheim
Description: Based upon the recently published American Academy of Neurology guidelines on the treatment to tics, this webinar will guide providers on the comprehensive evaluation of people with tics, including assessment of comorbid disorders. The evidence to support the use of behavioral therapies and pharmacological treatments for tics will be reviewed, with discussion of how to safely prescribe these interventions in clinical practice.
Dr. Tamara Pringsheim is an Associate Professor with the Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences at the University of Calgary. She is the program lead for the Tourette and Pediatric Movement Disorder program at Alberta Children’s Hospital and the Deputy Director of the Mathison Centre for Mental Health Research and Education. She also works as an evidence-based medicine methodologist for the American Academy of Neurology.
Dr. Pringsheim completed her residency in neurology at the University of Toronto and a fellowship in movement disorders and neuropsychiatry at the Toronto Western Hospital, and her Master of Science in Clinical Epidemiology. Her research program is focused on rational pharmacotherapy for neurological and mental health disorders, using knowledge synthesis and translation strategies.
She has developed clinical practice guidelines and tools for clinicians, and nationally implemented educational curricula with the goal of improving the safety, effectiveness and appropriateness of care.